The board of directors of Mediwelcome Healthcare Management & Technology Inc. (the ``Company'', together with its subsidiaries, the ``Group'') hereby announces that (i) Mr. Sui Huijun (``Mr. Sui'') has resigned as an executive Director; (ii) Ms. Zhang Yitao (``Ms. Zhang'') has resigned as a non-executive Director; and (iii) Mr. Fei John Xiang (``Mr. Fei'') has resigned as an independent non- executive Director, all with effect from 12 March 2024. Following the resignation of the Directors as mentioned above, the composition of the Board committees has changed with effect from 12 March 2024 as follows: Mr. Fei ceased to be the chairman of the remuneration committee of the Company (the ``Remuneration Committee''), a member of the audit committee of the Company (the ``Audit Committee'') and a member of the nomination committee of the Company (the ``Nomination Committee''); Mr. David Zheng Wang, an independent non-executive Director, has been redesignated as the chairman of the Remuneration Committee and appointed as a member of the Audit Committee; and Mr. Yang Xiaoxi, an independent non-executive Director, has been appointed as a member of the Nomination Committee.